Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacological management of transthyretin amyloid cardiomyopathy: a scoping review.
Rehman S, Masthan SS, Ibrahim R, Pham HN, Hassan D, Ahmad F, Asif MS, Safdar A, Anwar Z, Raza S, William P. Rehman S, et al. Among authors: william p. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):547-556. doi: 10.1093/ehjcvp/pvae044. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38830793 Review.
A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019.
Chirinos JA, Lopez-Jaramillo P, Giamarellos-Bourboulis EJ, Dávila-Del-Carpio GH, Bizri AR, Andrade-Villanueva JF, Salman O, Cure-Cure C, Rosado-Santander NR, Cornejo Giraldo MP, González-Hernández LA, Moghnieh R, Angeliki R, Cruz Saldarriaga ME, Pariona M, Medina C, Dimitroulis I, Vlachopoulos C, Gutierrez C, Rodriguez-Mori JE, Gomez-Laiton E, Cotrina Pereyra R, Ravelo Hernández JL, Arbañil H, Accini-Mendoza J, Pérez-Mayorga M, Milionis C, Poulakou G, Sánchez G, Valdivia-Vega R, Villavicencio-Carranza M, Ayala-García RJ, Castro-Callirgos CA, Alfaro Carrasco RM, Garrido Lecca Danos W, Sharkoski T, Greene K, Pourmussa B, Greczylo C, Ortega-Legaspi J, Jacoby D, Chittams J, Katsaounou P, Alexiou Z, Sympardi S, Sweitzer NK, Putt M, Cohen JB; FERMIN Investigators. Chirinos JA, et al. Nat Metab. 2022 Dec;4(12):1847-1857. doi: 10.1038/s42255-022-00698-3. Epub 2022 Nov 7. Nat Metab. 2022. PMID: 36344766 Free PMC article. Clinical Trial.
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ; TRANSFORM-HF Investigators. Mentz RJ, et al. JAMA. 2023 Jan 17;329(3):214-223. doi: 10.1001/jama.2022.23924. JAMA. 2023. PMID: 36648467 Free PMC article. Clinical Trial.
KCCQ total symptom score, clinical outcome measures, and adverse events associated with omecamtiv mecarbil for heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Ibrahim R, Olagunju A, Terrani K, Takamatsu C, Khludenev G, William P. Ibrahim R, et al. Among authors: william p. Clin Res Cardiol. 2023 Aug;112(8):1067-1076. doi: 10.1007/s00392-023-02172-w. Epub 2023 Feb 17. Clin Res Cardiol. 2023. PMID: 36800016
Fundamentals of Light Chain Cardiac Amyloidosis: A Focused Review.
Latif A, Lateef N, Razzaq F, Kapoor V, Ahsan MJ, Ashfaq M, Iftikhar A, Anwer F, Holmberg M, William P. Latif A, et al. Among authors: william p. Cardiovasc Hematol Disord Drug Targets. 2020;20(4):274-283. doi: 10.2174/1871529X20666201130110036. Cardiovasc Hematol Disord Drug Targets. 2020. PMID: 33256586 Review.
44 results